Skip to content
10-K

Annual Report

Maravai LifeSciences Holdings, Inc. MRVI

0001823239-26-000011

← back to feed
Filed
Feb 26, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Diluted FY 2025 · Dec 31, 2025 144.36M sh
Shares Diluted FY 2025 · Dec 31, 2024 137.91M sh
Shares Diluted FY 2025 · Dec 31, 2023 131.92M sh
Capex FY 2025 · Dec 31, 2025 $13.15M
Capex FY 2025 · Dec 31, 2024 $29.66M
Capex FY 2025 · Dec 31, 2023 $65.55M
Operating Cash Flow FY 2025 · Dec 31, 2025 −$57.57M
Operating Cash Flow FY 2025 · Dec 31, 2024 $7.47M
Operating Cash Flow FY 2025 · Dec 31, 2023 $126.22M
Long Term Debt FY 2025 · Dec 31, 2025 $286.33M
Long Term Debt FY 2025 · Dec 31, 2024 $290.49M
Short Term Debt FY 2025 · Dec 31, 2025 $5.44M
Short Term Debt FY 2025 · Dec 31, 2024 $5.44M
Cash And Equivalents FY 2025 · Dec 31, 2025 $216.89M
Cash And Equivalents FY 2025 · Dec 31, 2024 $322.4M
Stockholders Equity FY 2025 · Dec 31, 2025 $212.38M
Stockholders Equity FY 2025 · Dec 31, 2024 $325.29M
Current Liabilities FY 2025 · Dec 31, 2025 $44.92M
Current Liabilities FY 2025 · Dec 31, 2024 $56.97M
Total Liabilities FY 2025 · Dec 31, 2025 $397.87M
Total Liabilities FY 2025 · Dec 31, 2024 $431.04M
Current Assets FY 2025 · Dec 31, 2025 $296.25M
Current Assets FY 2025 · Dec 31, 2024 $429.15M
Total Assets FY 2025 · Dec 31, 2025 $770.58M
Total Assets FY 2025 · Dec 31, 2024 $1.01B
Eps Diluted FY 2025 · Dec 31, 2025 −$0.90
Eps Diluted FY 2025 · Dec 31, 2024 −$1.05
Eps Diluted FY 2025 · Dec 31, 2023 −$0.90
Eps Basic FY 2025 · Dec 31, 2025 −$0.90
Eps Basic FY 2025 · Dec 31, 2024 −$1.05
Eps Basic FY 2025 · Dec 31, 2023 −$0.90
Sga Expense FY 2025 · Dec 31, 2025 $145.12M
Sga Expense FY 2025 · Dec 31, 2024 $161.77M
Sga Expense FY 2025 · Dec 31, 2023 $151.39M
Rd Expense FY 2025 · Dec 31, 2025 $17.4M
Rd Expense FY 2025 · Dec 31, 2024 $19.22M
Rd Expense FY 2025 · Dec 31, 2023 $17.28M
Net Income FY 2025 · Dec 31, 2025 −$130.77M
Net Income FY 2025 · Dec 31, 2024 −$144.85M
Net Income FY 2025 · Dec 31, 2023 −$119.03M
Operating Income FY 2025 · Dec 31, 2025 −$215.27M
Operating Income FY 2025 · Dec 31, 2024 −$235.62M
Operating Income FY 2025 · Dec 31, 2023 −$31.65M
Gross Profit FY 2025 · Dec 31, 2025 $33.99M
Gross Profit FY 2025 · Dec 31, 2024 $108.31M
Gross Profit FY 2025 · Dec 31, 2023 $140.2M
Cost Of Revenue FY 2025 · Dec 31, 2025 $151.75M
Cost Of Revenue FY 2025 · Dec 31, 2024 $150.88M
Cost Of Revenue FY 2025 · Dec 31, 2023 $148.74M
Revenue FY 2025 · Dec 31, 2025 $185.74M
Revenue FY 2025 · Dec 31, 2024 $259.19M
Revenue FY 2025 · Dec 31, 2023 $288.95M